Key Events This Week
30 Mar: Stock declines 0.95% amid broader market sell-off
1 Apr: Significant open interest surge in derivatives despite price drop
2 Apr: Lupin upgraded to Strong Buy by MarketsMOJO
2 Apr: Week closes at Rs.2,276.80, down 2.49%
30 March 2026: Market Sell-Off Hits Lupin
On 30 March, Lupin Ltd. closed at Rs.2,312.70, down Rs.22.25 or 0.95%, amid a sharp decline in the broader market. The Sensex plunged 2.29% to 32,182.38, reflecting widespread selling pressure. Lupin’s volume was 25,593 shares, with delivery volumes rising 8.79% over the five-day average, indicating increased investor participation despite the price drop. The stock’s decline was less severe than the Sensex, suggesting relative resilience in a volatile environment.
1 April 2026: Derivatives Activity Surges Amid Price Weakness
Lupin’s derivatives segment saw a notable 10.84% surge in open interest on 1 April, rising to 21,136 contracts from 19,069 the previous day. Futures volume was robust at 13,296 contracts, with a futures value of approximately ₹26,104.40 lakhs and options notional value exceeding ₹10,737.93 crores. Despite this heightened activity, the stock price declined 1.69% to Rs.2,273.60, underperforming the Sensex, which gained 1.97% to 32,814.97.
The stock’s short-term technicals showed weakness, trading below its 5-day and 20-day moving averages, while still above longer-term averages, indicating a consolidation phase. Intraday lows touched Rs.2,262.80, reflecting selling pressure. The surge in open interest alongside falling prices suggests fresh positions were being established, possibly signalling directional bets or hedging strategies amid uncertainty.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
2 April 2026: Upgrade to Strong Buy Reflects Robust Fundamentals
On 2 April, Lupin Ltd. was upgraded by MarketsMOJO from a Buy to a Strong Buy rating, reflecting its robust financials and attractive valuation. The company’s quality rating improved due to a low Debt to Equity ratio of 0.10 times, strong operating profit margins of 33.60%, and consistent net sales growth at an annual rate of 11.42%. Return on Capital Employed (ROCE) peaked at 22.22%, while Return on Equity (ROE) remained healthy at 22%.
The valuation metrics supported the upgrade, with a Price to Book Value ratio of 5.4 and an exceptionally low PEG ratio of 0.3, indicating undervaluation relative to earnings growth. Lupin’s profit before tax excluding other income surged 43.6% to ₹1,833.91 crores in the latest quarter, supported by record quarterly net sales of ₹7,167.52 crores. Institutional investors hold a significant 47.08% stake, underscoring confidence in the company’s prospects.
Despite a slight price decline of 0.14% on 2 April to Rs.2,276.80, the upgrade signals strong underlying momentum. Lupin’s consistent outperformance of the BSE500 index over the past three years and a total return of 15.69% in the last year reinforce the positive outlook.
Want to dive deeper on Lupin Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Daily Price Comparison: Lupin Ltd. vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-30 | Rs.2,312.70 | -0.95% | 32,182.38 | -2.29% |
| 2026-04-01 | Rs.2,273.60 | -1.69% | 32,814.97 | +1.97% |
| 2026-04-02 | Rs.2,276.80 | +0.14% | 32,839.65 | +0.08% |
Key Takeaways
Positive Signals: Lupin’s upgrade to Strong Buy by MarketsMOJO highlights its robust financial health, attractive valuation, and strong operational metrics. The company’s low leverage, high operating margins, and impressive returns on capital and equity underpin its quality credentials. Institutional ownership at 47.08% adds stability and confidence in the stock’s prospects. The stock’s ability to outperform the BSE500 index over three years and deliver a 15.69% return in the past year further supports a positive long-term view.
Cautionary Notes: Despite strong fundamentals, Lupin’s stock price declined 2.49% over the week, underperforming the Sensex. The surge in derivatives open interest amid falling prices suggests increased market uncertainty and potential volatility. Short-term technical indicators remain weak, with the stock trading below its 5-day and 20-day moving averages. Investors should monitor price action closely for confirmation of trend direction before committing to new positions.
Conclusion
The week for Lupin Ltd. was marked by a complex interplay of cautious price action and strong fundamental validation. While the stock faced selling pressure and underperformed the broader market, the significant surge in derivatives activity and the upgrade to a Strong Buy rating by MarketsMOJO underscore underlying confidence in the company’s financial and operational strength. Lupin’s solid earnings growth, attractive valuation, and institutional backing position it well within the mid-cap pharmaceutical space. However, near-term volatility remains a factor, warranting close observation of market dynamics and technical signals in the coming weeks.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
